Brittany Meiling – Page 16 – Endpoints News

about the author

Brittany Meiling

editors@endpointsnews.com

Brittany Meiling on LinkedIn

author articles

Synthetic biology pioneer Synthorx recruits Cleave's Laura Shawver for top position

8 years ago

Roiled by financial turmoil, Teva's CEO boots R&D chief, top execs in C-suite overhaul

8 years ago

Under pressure from copycats, Roche sues Pfizer over Herceptin rival

8 years ago

Six top biotech VCs take a look at the latest trends, and offer their thoughts on 2018

8 years ago

French upstart Step Pharma raises €8.6M, taking immunosuppressive drugs to the clinic

8 years ago

After unexpected tie, Amsterdam wins 'coin toss' for new EMA HQ

8 years ago

Promentis closes $26M round and enters clinic; PellePharma gets breakthrough/orphan status; Shire appoints Dittrich ...

8 years ago

Bayer AG taps PeptiDream in billion-dollar deal

8 years ago

ScPharmaceuticals raises $90M in IPO with heart failure drug on deck

8 years ago

UK research campus expands; FDA clears NGS test for tumors; Orphazyme raises €80 million IPO

8 years ago

Booming Regeneron gets the green light for a major expansion

8 years ago

The Pentagon's compromise: drug approvals to remain in FDA's hands

8 years ago

Arsanis prices $40M IPO for infectious disease work

8 years ago

X4 raises $27M to take Sanofi’s old drug through pivotal trial

8 years ago

Johns Hopkins has $65M to spend on taking their drugs right up to human studies

8 years ago

Not your mom’s probiotic: GV-backed Evelo teams up with Mayo Clinic on microbiome drugs

8 years ago

Alkermes touts equal efficacy of monthly Vivitrol against daily Suboxone

8 years ago

Genentech inks $650M deal with protein degradation pioneer Arvinas

8 years ago

Mirati bails on lead drug, shifts focus to I/O program

8 years ago

San Diego’s stealthy Odonate surfaces with $173M IPO

8 years ago

Torque takes tumor tech out of stealth with $25M backing, new CEO

8 years ago

Google backs I/O startup Arcus in $107M deal

8 years ago

Novartis co-opts Homology's gene-editing tech for R&D pipeline

8 years ago

Sangamo joins biotech migration to Oyster Point with new HQ

8 years ago

First page Previous page 13 14 151617 18 Next page Last page